trans,trans-1,5-Diphenylpenta-1,4-dien-3-one, 98.0%, 10g

(2-Hydroxy-3-methylphenyl)boronic acid, 95.0%, 250mg

(2,2,6,6-Tetramethyl-4-piperidyl)methanol hydrochloride, 98%, 1g

GOLVATINIB, 95%, 5mg

Methyl benzo[d]oxazole-2-carboxylate, 95.0%, 250mg

(2,4-Dinitro-phenyl)-methyl-amine, 95.0%, 1g

(2S,3S)-2,3-Dihydroxybutane-1,4-diyl dibenzoate, 95.0%, 1g

[2-(6-chloro-1H-benzimidazol-2-yl)ethyl]amine dihydrochloride, 95.0%, 1g

1H-Pyrazolo[3,4-c]pyridin-3-amine, 95.0%, 250mg

2-Bromo-7-chlorobenzo[b]thiophene, 97%, 50mg

GC capillary column ROTI®Cap-1, 10 m, 0.32 mm, 1.00 µm, 1 Piece(s)

Sample beakers ROTILABO®, 100 ml, 100 Piece(s)

4-chloro-3-fluoro-3'-pyrrolidinomethyl benzophenone, 97.0%, 1g